7Baggers
Quarterly
Annual
    Unit: USD2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
      
    		              
      assets
    		              
      current assets:
    		              
      cash and cash equivalents
    		54,480,000 48,299,000 34,447,000 32,894,000 35,604,000 31,652,000 27,771,000 54,598,000 62,545,000 63,543,000     
      accounts receivable
    		31,988,000 32,173,000 33,672,000 30,932,000 28,069,000 24,855,000 25,170,000 24,356,000 25,855,000 28,992,000 28,771,000 23,410,000 18,223,000  
      prepaid expenses
    		5,342,000 3,576,000 4,475,000 5,420,000 5,009,000 4,079,000 4,967,000 5,600,000 6,105,000 2,605,000 3,634,000 5,458,000   
      other current assets
    		1,711,000 1,388,000 1,573,000 1,677,000 1,170,000 1,459,000 1,718,000 2,093,000 2,303,000 888,000 1,287,000 1,332,000   
      total current assets
    		93,521,000 85,436,000 74,167,000 70,923,000 69,852,000 62,045,000 59,626,000 86,647,000 96,808,000 96,028,000 90,251,000 86,406,000 89,678,000  
      notes receivable
    		3,000,000 3,000,000 3,000,000            
      property, equipment, and software
    		20,963,000 20,513,000 19,672,000 18,851,000 18,314,000          
      right-of-use-assets
    		18,062,000 18,926,000 16,054,000 14,151,000 14,304,000 15,734,000 12,388,000 13,438,000       
      other assets
    		7,715,000 7,065,000 7,197,000 7,038,000 6,502,000 5,825,000 4,532,000 4,529,000 4,484,000 4,151,000 3,783,000 3,499,000 3,356,000  
      total assets
    		143,261,000 134,940,000 120,090,000 110,963,000 108,972,000 101,740,000 94,053,000 121,493,000 123,783,000 115,602,000 110,127,000 104,951,000 106,085,000 1 
      ​
    		              
      liabilities and stockholders’ equity
    		              
      current liabilities:
    		              
      accounts payable
    		867,000 1,175,000 816,000 3,364,000 2,212,000 1,341,000 868,000 1,290,000 1,685,000 1,185,000 879,000 1,189,000 2,528,000  
      accrued expenses and other current liabilities
    		20,393,000 16,460,000 11,862,000 9,513,000 13,841,000 10,629,000 8,129,000 7,403,000 11,665,000 10,804,000 8,963,000 6,557,000 5,578,000  
      current portion of lease liabilities
    		6,076,000 5,935,000 5,194,000 4,529,000 4,256,000 4,403,000 4,761,000 5,013,000 4,030,000      
      total current liabilities
    		27,336,000 23,570,000 17,872,000 17,406,000 20,309,000 16,373,000 13,758,000 13,706,000 17,380,000 11,989,000 9,842,000 7,746,000 8,106,000  
      lease liabilities, net of current portion
    		14,236,000 15,193,000 12,803,000 10,931,000 11,181,000 12,090,000 8,052,000 8,642,000 2,959,000      
      other non-current liabilities
    		2,150,000              
      total liabilities
    		43,722,000 38,763,000 30,675,000 28,337,000 31,490,000 28,463,000 21,810,000 22,348,000 20,339,000 12,432,000 10,321,000 8,243,000 8,644,000  
      commitment and contingencies
    		              
      stockholders’ equity:
    		              
      preferred stock, 0.001 par value; 100,000 shares authorized, no shares issued and outstanding as of december 31, 2024 and december 31, 2023, respectively
    		              
      class a common stock
    		95,000 93,000 92,000 90,000 88,000 88,000 82,000 74,000 71,000 67,000 67,000 66,000 66,000  
      class b common stock
    		34,000 35,000 36,000 38,000 39,000 39,000 41,000 41,000 43,000 46,000 46,000 47,000 47,000  
      additional paid-in capital
    		243,935,000 240,224,000 236,327,000 231,881,000 226,877,000 224,710,000 223,766,000 240,075,000 244,260,000 241,045,000 240,501,000 233,607,000 226,717,000  
      accumulated deficit
    		-170,109,000 -170,230,000 -171,645,000 -173,471,000 -172,932,000 -173,555,000 -175,383,000 -176,012,000 -178,863,000 -179,357,000 -180,896,000 -178,474,000 -171,209,000  
      accumulated other comprehensive loss
    		-734,000 -199,000 -509,000 -484,000 -406,000 -548,000 -378,000 -473,000 -504,000 -672,000 -582,000 -375,000 -325,000  
      total stockholders’ equity attributable to enfusion, inc.
    		73,221,000 69,923,000 64,301,000 58,054,000 53,666,000 50,734,000 48,128,000 63,705,000 65,007,000 61,129,000 59,136,000 54,871,000   
      non-controlling interests
    		26,318,000 26,254,000 25,114,000 24,572,000 23,816,000 22,543,000 24,115,000 35,440,000 38,437,000 42,041,000 40,670,000 41,837,000 42,145,000  
      total stockholders’ equity
    		99,539,000 96,177,000 89,415,000 82,626,000 77,482,000 73,277,000         
      total liabilities and stockholders’ equity
    		143,261,000 134,940,000 120,090,000 110,963,000 108,972,000 101,740,000         
      preferred stock, 0.001 par value; 100,000 shares authorized, no shares issued and outstanding as of september 30, 2024 and december 31, 2023, respectively
    		              
      preferred stock, 0.001 par value; 100,000 shares authorized, no shares issued and outstanding as of june 30, 2024 and december 31, 2023, respectively
    		              
      preferred stock, 0.001 par value; 100,000 shares authorized, no shares issued and outstanding as of march 31, 2024 and december 31, 2023, respectively
    		              
      preferred stock, 0.001 par value; 100,000 shares authorized, no shares issued and outstanding as of december 31, 2023 and december 31, 2022, respectively
    		              
      property and equipment
    		     18,136,000 17,507,000 16,879,000 15,759,000 15,423,000 16,093,000 15,046,000 13,051,000  
      preferred stock, 0.001 par value; 100,000 shares authorized, no shares issued and outstanding as of september 30, 2023 and december 31, 2022, respectively
    		              
      liabilities and stockholders' equity
    		              
      stockholders' equity:
    		              
      preferred stock, 0.001 par value; 100,000 shares authorized, no shares issued and outstanding as of june 30, 2023 and december 31, 2022, respectively
    		              
      total stockholders' equity
    		      72,243,000 99,145,000 103,444,000 103,170,000 99,806,000 96,708,000   
      total liabilities and stockholders' equity
    		      94,053,000 121,493,000 123,783,000 115,602,000 110,127,000 104,951,000   
      right-of-use assets
    		        6,732,000      
      other liabilities
    		         443,000 479,000 497,000 538,000  
      cash
    		          56,559,000 56,206,000 64,365,000 1 
      commitments and contingencies
    		              
      prepaid expenses and other current assets
    		            7,090,000  
      liabilities, preferred units, stockholders' equity and members’ deficit
    		              
      current portion of long-term debt
    		              
      long-term debt, net of discount and issuance costs
    		              
      preferred units:
    		              
      class c-1 units, no par value, 28.777 units issued and outstanding as of december 31, 2020
    		              
      class c-2 units, no par value, 12.219 units issued and outstanding as of december 31, 2020
    		              
      class d units, no par value, 12.778 units issued and outstanding as of december 31, 2020
    		              
      total preferred units
    		              
      stockholders' equity/members’ deficit:
    		              
      members' deficit, no par value, 47.968 units issued and outstanding as of december 31, 2020
    		              
      preferred stock, par value 0.001 per share, 100,000,000 shares authorized, no shares issued and outstanding as of december 31, 2021
    		              
      total stockholders’ equity attributable to enfusion, inc. /members’ deficit
    		            55,296,000  
      total stockholders' equity/ members’ deficit
    		            97,441,000  
      total liabilities, preferred units and stockholders’ equity/members’ deficit
    		            106,085,000  
      stockholder's equity
    		              
      common stock
    		             1 
      total stockholder's equity
    		             1 
      ●
    		              
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.